Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region
Objective: scientific rationale of changing approaches to medical care payment for hospitalization of patients suffering from severe asthma (SA) that require the prescription of biologic disease-modifying drugs (bDMDs) within the constraints of diagnosis-related groups (DRGs) on the level of the Mos...
Saved in:
Main Authors: | A. D. Ermolaeva (Author), V. S. Krysanova (Author), T. N. Ermolaeva (Author), K. I. Polyakova (Author), K. A. Kokushkin (Author) |
---|---|
Format: | Book |
Published: |
IRBIS LLC,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and economic assessment of feasibility of using quadritherapy in patients with reduced ejection fraction chronic heart failure in medical organizations of the Moscow Region
by: A. D. Ermolaeva, et al.
Published: (2023) -
ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES
by: V. S. Krysanova, et al.
Published: (2021) -
Economic burden of systemic sclerosis: systematic review
by: D. L. Klabukova, et al.
Published: (2020) -
Technologies for the prevention of meteopathic reactions in children with bronchial asthma in the Moscow region
by: N. A. Lyan, et al.
Published: (2023) -
Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome
by: O. I. Ivakhnenko, et al.
Published: (2022)